Not known Factual Statements About Glecaprevir
Given that Pirfenidone is metabolised in the CYP1A2 enzyme pathway, any drug which inhibits this enzyme is likely to precipitate the toxicity of pirfenidone: concomitant therapy would be to be averted.Usage of potent CYP1A2 inhibitors ought to be discontinued in advance of initiating treatment method and averted through treatment; if potent CYP1A2